Access to antiviral therapy is expected to broaden for patients with COVID-19 in the near future. Urgent care centers are well positioned to offer key advantages for patients compared with other settings—most significantly, considering that the timing of oral therapeutic initiation is essential to reducing viral load, 7-day walk-in access. To help ensure urgent care providers are well armed with the most up-to-date information, the Urgent Care Association and the College of Urgent Care Medicine will host a Town Hall Q & A covering access, indications and contraindications, dispensing, prescribing, follow-up, reporting, and alternative therapies. Joseph Toscano, MD, FCUDM, a longtime member of the JUCM Editorial Board, will facilitate the discussion with Derek Eisnor, MD, clinical lead at the U.S. Department of Health and Human Services and Michael Anderson, MD, clinical team, pediatrics at HHS. The Town Hall, scheduled for February 22 from noon to 1 pm, Central, is for UCA members only. For registration or more information, click here.
UCA Members: Want to Treat COVID-19 Patients with Antivirals? Now Is the Time to Prepare